These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6378807)

  • 1. Comparison of three different methods of monitoring unwanted effects during antihypertensive therapy.
    Borghi C; Pallavini G; Comi D; Grillo G; Lombardo M; Mantero O; Minetti L; Selvini A; Suppa G
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):324-8. PubMed ID: 6378807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advantages of a fixed association of oxprenolol-chlorthalidone, as opposed to chlorthalidone alone, in the treatment of chronic essential arterial hypertension].
    Baronchelli A; Agosta R; Verdecchia P; Bichisao E
    Clin Ter; 1981 Apr; 97(1):63-9. PubMed ID: 7026137
    [No Abstract]   [Full Text] [Related]  

  • 3. Antihypertensive activity of a fixed combination of oxprenolol and chlorthalidone in mild to moderate arterial hypertension.
    Motolese M; Agabiti-Rosei E; Carotti A; Innocenti P; Montervino C; Solinas E; Toso M; Muiesan G
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):332-7. PubMed ID: 7409934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of essential hypertension with oxprenolol and chlorthalidone in a fixed combination.
    Karachalios GN
    Int J Clin Pharmacol Res; 1983; 3(3):153-6. PubMed ID: 6679518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension.
    Angelino PF; Alvino-Demartino A; Mappa R; Donati C
    Int J Clin Pharmacol Ther Toxicol; 1985 Sep; 23(9):501-5. PubMed ID: 3902676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of oxprenolol plus chlorthalidone in fixed combination against chlorthalidone alone in mild to moderate essential hypertension; a clinical trial.
    Gruppillo P; Tomasi AM; Masoni A; Finzi C
    G Ital Cardiol; 1980; 10(4):476-9. PubMed ID: 7002694
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
    Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
    Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the administration time on the antihypertensive and hypokalaemic effects of chlorthalidone in patients with primary hypertension.
    Carpentiere G; Marino S; Castello F
    Int J Clin Pharmacol Res; 1985; 5(2):109-12. PubMed ID: 3894256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Captopril and oxprenolol in a fixed combination with thiazide diuretics: comparison of their antihypertensive efficacy and metabolic effects.
    Costa FV; Borghi C; Ambrosioni E
    Clin Ther; 1984; 6(5):708-18. PubMed ID: 6383615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reduction of left ventricular hypertrophy and increased tolerance to exertion in hypertensive patients after antihypertensive therapy with slow-release oxprenolol and chlorthalidone].
    Sau F; Seguro C; Alberti D; Cherchi A
    Cardiologia; 1986 Sep; 31(9):701-8. PubMed ID: 2949838
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ergometric studies for supplementary evaluation of antihypertensive therapy].
    Franz IW; Lohmann FW
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():325-7. PubMed ID: 347807
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of chlorthalidone, oxprenolol, and their combination in hypertensive blacks: a randomized double-blind crossover study.
    Obel AO
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):465-70. PubMed ID: 2471894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of refractory hypertension with a fixed oxprenolol/chlorthalidone/hydralazine combination. Results of an open multicenter trial].
    Krönig B; Wendt G
    Med Welt; 1983 Sep; 34(35):941-4. PubMed ID: 6355745
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ergometry in the assessment of antihypertensive treatment (author's transl)].
    Franz IW; Lohmann FW
    Dtsch Med Wochenschr; 1978 Sep; 103(38):1478-81. PubMed ID: 688878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
    Fogari R; Zoppi A
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of long term oxprenolol and chlorthalidone singly and in combination in hypertensive blacks.
    Obel AO
    Jpn Heart J; 1990 Mar; 31(2):183-92. PubMed ID: 2192098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
    Dal Negro RW; Zoccatelli O; Pomari C; Trevisan F; Turco P
    Int J Clin Pharmacol Res; 1986; 6(4):283-9. PubMed ID: 2875954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fenquizone in the medium term treatment of essential hypertension. Double-blind comparison with chlorthalidone and placebo].
    Pasotti C; Rossi R; Gandolfi P
    Minerva Med; 1981 Nov; 72(46):3105-10. PubMed ID: 7029355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.